Download presentation
Published byHilda Young Modified over 9 years ago
1
ACLS Workshop DCH Regional Medical Center and Harrison School of Pharmacy, Auburn University
2
General Administration Concepts
Follow each dose with mL NS Assists in drug distribution Prefilled 10 mL syringe available Expiration times General times provided DCH policy for medication prepared at bedside – 8 hours Administration must occur within 1 hour of preparation Infusions must be completed within 8 hours or be replaced by a pharmacy admixed product Labeling of IV push doses not necessary if administered immediately after preparation Labeling of infusions Patient Identification Names/ amounts of all ingredients Names or initials of preparer Date and time prepared Expiration date and time
3
Alternative Routes of Administration
Intraosseous Into the bone Drug reaches heart in approximately 2 minutes Endotracheal NAVEL Naloxone, atropine, vasopressin, epinephrine, lidocaine Dose is 2 times the IV/IO dose Dilute in 10 mL fluid NS – most common diluent Sterile water- may improve absorption of epinephrine or lidocaine
4
Epinephrine Use – First line VF/VT, PEA, asystole Normal Dosing
1 mg via prefilled syringe (1:10,000 of 1mg/10mL) IVP Higher doses (up to 0.2 mg/kg) may be used if 1 mg dose fails – rarely done Frequency – every 3-5 minutes Every other defibrillation-drug administration sequence Alternative Dosing Continuous Infusion
5
Epinephrine Preparation
Infusion Vial – 1:1,000 solution (30 mL) 1 mg/mL = 30 mg/vial Step 1 – withdraw 1 mg (1mL) from vial Step 2 – add epinephrine to 250 mL D5W or NS Final concentration – 4 mcg/mL Alternative strengths Double strength: add 2 mg (2 mL) epinephrine to 250 mL D5W or NS [Final concentration 8 mcg/mL] Triple strength: add 3 mg (3 mL) epinephrine to 250 mL D5W or NS [Final concentration 12 mcg/mL] Alternative (AHA dose): add 30 mg epinephrine to 250 mL D5W or NS [Final concentration 120 mcg/mL] Protect from light Expires 24 hour after preparation Usual starting dose – 0.05 mcg/kg/min (~ 200 mcg/min or 100 mL/hr)
6
Atropine Use – PEA and asystole Dosing 1 mg prefilled syringe
Frequency – every 3-5 minutes Alternate with epinephrine Maximum of 3 doses (i.e. 3 mg) Note: not for continuous infusion
7
Vasopressin Use – Alternative to 1st or 2nd dose of epinephrine in VF/VT, PEA, or asystole (Only 1 dose is administered) Also used as adjunct to NE or DA in shock Available – 20 unit vial (20 units/2 mL), 100 unit vial Dosing Cardiac arrest - 40 units IVP Shock – units/min IV continuous infusion Preparation (for infusion) Step 1 – withdraw 250 units vasopressin Step 2 – add vasopressin to 250 mL D5W or NE Final concentration 1 unit/mL Expires 28 hours following preparation Refrigerate (not necessary in ACLS)
8
Amiodarone Use Dosing dependent on use
Refractory cardiac arrest Wide-Complex Tachycardia (Stable) i.e. tachycardia with pulses Dosing dependent on use Max cumulative dose: 2.2 g IV/24 hours Note: ANY dose during a medical emergency should be followed with a continuous infusion for at least 24 hours
9
Amiodarone Preparation and Administration
Cardiac Arrest Vial – 150 mg/ 3mL Step 1 - Withdraw 300 mg (2 vials) amiodarone (6mL) Note – Filter needles no longer required Step 2 – Administer IVP undiluted Step 3 – Follow with mL saline flush May repeat additional 150 mg (1 vial) IVP in 3-5 minutes
10
Amiodarone Preparation and Administration
Wide-Complex Tachycardia Vial – 150 mg/3mL Loading Dose Step 1 – withdraw 150 mg amiodarone Step 2 – add amiodarone to 100 mL D5W Final concentration – 1.5 mg/mL Administer over 10 minutes Expires 2 hours after preparation
11
Amiodarone Preparation and Administration
Maintenance Infusion Step 1 – Transfer 250 mL D5W to glass bottle (if Baxter bag unavailable) Step 2 – withdraw 450 mg amiodarone (3 vials) Alternative – withdraw 500 mg (3 vials) if able Step 3 – add amiodarone to 250 mL D5W Final Concentration 1.8 mg/mL Concentration with 500 mg : 2 mg/mL Administration 1 mg/min (360 mg) IV for six hours then 0.5 mg/min (540 mg) IV for 18 hours Requires in-line filter for administration Expires 12 hours after preparation
12
Lidocaine Use – alternative to amiodarone in VT/VF, stable VT, wide-complex tachycardia, wide complex PSVT May be given via ET tube Dosing Initial Bolus – 1mg/kg – 1.5mg/kg IVP at mg/min May repeat 50% original dose in 5-10 minutes Max 3 doses or 3 mg/kg Infuse at 1-4 mg/min following bolus administration Available Premixed solution (2 gm/500 mL D5W, 1 gm/250 mL D5W) Prefilled syringe (100 mg/5mL) 1 gm vial (20 mg/mL)
13
Lidocaine Preparation and Administration
Preparation of infusion (if not using premixed bag) Step 1 – withdraw 100 mL from 250 mL D5W bag Step 2 – withdraw 2 gm (2 vials) lidocaine Note: Not in DCH ACLS carts Step 3 – inject into 150 mL D5W Notes: Contraindicated in WPW Cannot administer through same IV line as epinephrine or norepinephrine
14
Adenosine Use – First line narrow-complex PSVT
Do not use in VT Note – may cause transient asystole or bradycardia Available in 6 mg vial (3mg/2mL) Preparation Withdraw appropriate dose from vial Is not diluted for infusion Dosing and administration Place patient in mild reverse Trendelenburg position Initial dose – 6 mg IV push rapidly over 1-3 seconds Follow immediately with 20 mL NS bolus and elevate extremity May repeat 12 mg in 1-2 minutes if no response up to 2 additional doses
15
Norepinephrine Use – Hypotension and shock
Available in 4 mg vial (4mg/4mL) Preparation Step 1 – withdraw 4 mg (1 vial) Step 2 – add to 250 mL NS or D5W Final Concentration – 16 mcg/mL Protect from light Expires 24 hours after preparation Initial infusion rate: 5 mcg/min
16
Phenylephrine Use: hypotension with tachycardia, paroxysmal SVT
Preparation Step 1 – withdraw 10 mg (1 vial) Note: DCH – withdraw 40 mg Not in DCH carts Step 2 – add to 250 mL D5W or NS Final Concentration – 40 mcg/mL Protect from light Expires 48 hours after preparation Initial infusion rate: mcg/min Precautions – sulfite allergy
17
Dopamine Use – hypotension Premixed bag Preparation
400 mg/250 mL D5W Concentration – 1.6 mg/mL Preparation Only if premixed bag unavailable Add 400 mg dopamine to 250 mL D5W or NS May also add 800 mg if require concentrated infusion Initial infusion rate: 5-10 mcg/kg/min Titrate to patient response Usually to MAP ≥ 65 mmHg or SBP ≥ 90 mmHg Precautions – tachycardia, arrhythmias Do not administer with sodium bicarbonate
18
Magnesium Sulfate Use – torsades de pointes or hypomagnesemia, refractory VF (after lidocaine) Available – 1gm/2mL vial Preparation Cardiac arrest Step 1 – withdraw 10 mL D5W into syringe Step 2 - withdraw 1-2 gm Mg (1-2 vials) into same syringe Final concentration mg/mL Administer IVP over at least 5 minutes Torsades de pointes when not in cardiac arrest Step 1 – withdraw 1-2 gm Mg (1-2 vials) Step 2 – add to 100 mL D5W Administer over 5-60 minutes IV
19
Calcium Chloride Use – CCB or BB overdose, hypocalcemia, hyperkalemia, prophylactically before IV CCB to prevent hypotension Not usually used in cardiac arrest Available Prefilled syringe (1gm/10mL) Also available as Calcium Gluconate 1gm/10mL if only peripheral access available) Dosing and administration 8-16 mg/kg (~ 5-10 mL or prefilled syringe) slow IVP Repeat as needed Do not administer with sodium bicarbonate
20
Naloxone Use – opiod overdose Available Dosing 1 mL vial (0.4 mg/mL)
10 mL vial (0.4 gm/mL) Dosing 0.4-2 mg IVP every 2 minutes May give up to 10 mg in < 10 minutes
21
Sodium Bicarbonate Use – hyperkalemia, bicarbonate-responsive acidosis (i.e. DKA), alkalinize urine (ASA or TCA overdose), prolonged resuscitation Not recommended for routine use in cardiac arrest Available 50 mEq prefilled syringe (1 mEq/mL) Dosing 1 mEq/kg IV bolus May repeat 50% dose in 10 minutes
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.